City

Boston (1)

Graz (1)

Innsbruck (1)

Linz (1)

Vienna (1)

Condition

COVID-19 (1)

Germ Cell Tumor (1)

Ovarian Cancer (1)

Overall Status

Active, not recruiting (1)

Not yet recruiting (1)

Unknown status (1)

Phase

phase 2 (1)

phase 2/phase 3 (1)

phase 3 (1)

Sponsor

Beth Israel Deaconess Medical Center (1)

Gustave Roussy, Cancer Campus, Grand Paris (1)

Medical University of Vienna (1)

Study Documents

Intervention Type

drug (3)

other (2)

Funder Type

Other (3)

Study Type

Interventional (3)

thromboprophylaxis

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Germ Cell Tumor Trial (Thromboprophylaxis)

Not yet recruiting

Germ Cell Tumor

Thromboprophylaxis

(no location specified)

May 16, 2023

Ovarian Cancer Trial in Boston (Enoxaparin, Enoxaparin + Rosuvastatin, Thromboprophylaxis)

Active, not recruiting

Ovarian Cancer

Enoxaparin
+2 more

Boston, Massachusetts
+1 more

Oct 13, 2022

COVID-19 Trial in Austria (Chloroquine or Hydroxychloroquine, Lopinavir/Ritonavir, Best standard of care)

Unknown status

COVID-19

Chloroquine or Hydroxychloroquine
+11 more

Innsbruck, Tirol, Austria
+8 more

Feb 25, 2021